SERONEGATIVE ANTIPHOSPHOLIPID SYNDROME-ASSOCIATED WITH PLASMINOGEN-ACTIVATOR INHIBITOR

被引:12
作者
JOSEPH, J [1 ]
SCOPELITIS, E [1 ]
机构
[1] LSU,MED CTR,DEPT MED,RHEUMATOL SECT,NEW ORLEANS,LA 70112
关键词
THROMBOSIS; ANTICARDIOLIPIN ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR; VASCULOPATHY;
D O I
10.1177/096120339400300312
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antiphospholipid syndrome is characterized by thrombosis, recurrent fetal loss, thrombocytopenia and is associated with the presence of antiphospholipid antibodies, especially anticardiolipin antibodies. We present a patient with the clinical features of antiphospholipid syndrome, namely recurrent venous and arterial thrombosis, recurrent abortions, thrombocytopenia and livido reticularis but with persistently negative serology for any type of antiphospholipid antibody. The possible existence of 'seronegative' antiphospholipid syndrome is proposed. Of additional interest in this patient is the presence of significantly elevated levels of plasminogen activator inhibitor. The role of this inhibitor, if any, in the antiphospholipid syndrome and/or seronegative antiphospholipid syndrome is not known and merits further study.
引用
收藏
页码:201 / 203
页数:3
相关论文
共 10 条
[1]  
GHARAVI AE, 1989, ANN RHEUM DIS, V46, P1
[2]  
HAMSTEN A, 1987, LANCET, V2, P3
[3]   INCREASED PLASMA-LEVELS OF A RAPID INHIBITOR OF TISSUE PLASMINOGEN-ACTIVATOR IN YOUNG SURVIVORS OF MYOCARDIAL-INFARCTION [J].
HAMSTEN, A ;
WIMAN, B ;
DEFAIRE, U ;
BLOMBACK, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (25) :1557-1563
[4]  
JORGENSEN M, 1987, THROMB HAEMOSTASIS, V58, P872
[5]  
JURADO M, 1992, THROMB HAEMOSTASIS, V68, P516
[6]  
PARAMO JA, 1985, THROMB HAEMOSTASIS, V54, P713
[7]   A PRIMARY THROMBOTIC SYNDROME - ABSENCE OF ANTIPHOSPHOLIPID ANTIBODIES [J].
SABBAGA, J ;
NETO, JF ;
CHADDAD, R ;
CECCONELLO, I ;
DEOLIVEIRA, RM .
CLINICAL RHEUMATOLOGY, 1991, 10 (01) :81-83
[8]   INCREASED TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR GENE-EXPRESSION IN ATHEROSCLEROTIC HUMAN ARTERIES [J].
SCHNEIDERMAN, J ;
SAWDEY, MS ;
KEETON, MR ;
BORDIN, GM ;
BERNSTEIN, EF ;
DILLEY, RB ;
LOSKUTOFF, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) :6998-7002
[9]   PROMOTION AND SUBSEQUENT INHIBITION OF PLASMINOGEN ACTIVATION AFTER ADMINISTRATION OF INTRAVENOUS ENDOTOXIN TO NORMAL SUBJECTS [J].
SUFFREDINI, AF ;
HARPEL, PC ;
PARRILLO, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (18) :1165-1172
[10]   TISSUE PLASMINOGEN-ACTIVATOR INHIBITOR IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND THROMBOSIS [J].
VIOLI, F ;
FERRO, D ;
VALESINI, G ;
QUINTARELLI, C ;
SALIOLA, M ;
GRANDILLI, MA ;
BALSANO, F .
BRITISH MEDICAL JOURNAL, 1990, 300 (6732) :1099-1102